Hussein Tawbi, MD, PhD, presents the case of a 78-year-old man with metastatic melanoma and shares his initial impressions.
2023
Examining the Effects of COVID-19 Pandemic on Melanoma Diagnoses, Treatment, Outcomes
Patients diagnosed with melanoma in 2020 presented with thicker, more ulcerated, and more advanced tumors despite reduced treatment delays, according to study results published in the Journal of the American Academy of Dermatology.
Immunotherapy, Targeted Therapy Efficacy in Melanoma, and Managing Toxicities
During a recent Institute for Value-Based Medicine® event, speakers discussed the use of immunotherapy and targeted therapy to treat melanoma and managing the toxicities of these treatments.
Lifileucel Demonstrates Efficacy in Advanced Mucosal Melanoma Following Progression on Immune Checkpoint Inhibitors
Lifileucel demonstrated clinically meaningful activity in patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors, according to findings from a subgroup of patients in the phase 2 C-144-01 study.